Laura Koman advises health care and life sciences companies on transactional and regulatory matters, with a particular emphasis on digital health.
Laura has advised hospitals, health systems, provider groups, and established and emerging companies concerning e-health topics such as direct-to-consumer telemedicine, provider-to-provider consults, e-prescribing, licensure, remote supervision, reimbursement, patient consent, and corporate structure and corporate practice of medicine issues. She also has participated in structuring various health care transactions, including health care acquisitions, joint ventures, management service agreements, and other arrangements for the provision of professional, practice management, or administrative services. Laura's experience includes counseling clients on health care fraud and abuse issues, including compliance with the Stark Law and Anti-Kickback Statute.
On the life sciences side, Laura advises clients on issues surrounding the regulation of drug, medical device, food, dietary supplement, and cosmetic products by the FDA, CPSC, and other federal and state agencies and provides support to clients engaged in life sciences M&A and other transactions, including due diligence.
Laura maintains an active pro bono practice that includes providing advice to nonprofit organizations relating to governance and formation and volunteering with the D.C. Bar Association's Landlord Tenant Resource Center. She also recently represented an individual seeking social security disability benefits as a volunteer for the Washington Legal Clinical for the Homeless.
Laura is a member of the American Health Lawyers Association.
21st Century Cures Act—February 11, 2017, Deadline for Company Disclosure of Expanded Access Programs
- University of Maryland (J.D. summa cum laude 2015; Order of the Coif; Managing Editor, Maryland Law Review; B.A. in Government & Politics magna cum laude 2012; Honors College)
- District of Columbia and Maryland